Details for Patent: 9,937,075
Which drugs does patent 9,937,075 protect, and when does it expire?
Patent 9,937,075 protects XIPERE and is included in one NDA.
This patent has twenty-eight patent family members in thirteen countries.
Summary for Patent: 9,937,075
| Title: | Apparatus and methods for ocular injection |
| Abstract: | An apparatus includes a housing coupled to a medicament container, which is coupled to a needle. An injection assembly is disposed within the housing and includes an energy storage member and an actuation rod. A distal end portion of the actuation rod is disposed within the medicament container. The energy storage member can produce a force on a proximal end portion of the actuation rod sufficient to move the distal end portion of the actuation rod within the medicament container. This can convey at least a portion of a substance from the medicament container via the needle when a distal tip of the needle is disposed within a first region of a target location. The force is insufficient to move the distal end portion of the actuation rod within the medicament container when the distal tip of the needle is disposed within a second region of the target location. |
| Inventor(s): | Rafael Victor Andino, Vladimir ZARNITSYN, Jesse YOO, Christopher John Brooks, Trent John Kahute, Justin William Arsenault, David Jackson Trettin, Andrew Kent Bauer, Stephanie Elaine Lewis |
| Assignee: | Clearside Biomedical Inc |
| Application Number: | US15/714,441 |
|
Patent Claim Types: see list of patent claims | Device; Dosage form; |
Drugs Protected by US Patent 9,937,075
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | XIPERE | triamcinolone acetonide | SUSPENSION;INJECTION | 211950-001 | Oct 22, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,937,075
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014259694 | ⤷ Start Trial | |||
| Brazil | 112015027762 | ⤷ Start Trial | |||
| Canada | 2911290 | ⤷ Start Trial | |||
| Canada | 3121759 | ⤷ Start Trial | |||
| China | 105246529 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
